COVID-19 pandemic could provide India an opportunity to scale up the healthcare industry and be a major supplier of pharmaceutical products to the world, Hindustan Unilever Chairman & Managing Director Sanjiv Mehta said on Saturday.Making a case for restarting manufacturing APIs (Active Pharmaceutical Ingredients), Mehta said this would not only help India become the “affordable healthcare capital of the world" but would also be a massive growth engine for the country."I believe that just like Y2K crisis gave a stimulus to the IT industry in the country, the current pandemic could give momentum to the healthcare industry," said Mehta in his virtual keynote address at All Indian Management Association (AIMA) Foundation Day.The healthcare.